Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Bay Area Biotech CEOs React to s Travel Ban January 30, 2017 CytoSorbents Expands Distribution And Sales of CytoSorb To Treat Deadly Inflammation In Panama With DRGR July 16, 2017 Evotec and Sanofi Collaborate on Infectious Disease R&D Initiative March 7, 2018
CytoSorbents Expands Distribution And Sales of CytoSorb To Treat Deadly Inflammation In Panama With DRGR July 16, 2017